Medical Research
HOUSTON, Texas — An implantable “drug factory” the size of a pinhead could cure a patient’s cancer in less than a week! Those are the findings of a new study by bioengineers at Rice University who say the new treatment can completely...
Researcher Christina Caira reflects on use of AI in Parkinson’s Disease research Parkinson’s disease (PD) is the second most common neurodegenerative disorder, characterized by the degeneration of dopamine releasing regions in the brain....
Mission Bio: Pioneering cancer pathologist Jorge Reis-Filho’s lab at Memorial Sloan Kettering Cancer Center to develop best practices integrating Tapestri single-cell multi-omics capabilities SOUTH SAN FRANCISCO, March 1, 2022 — Mission...
2022/027 from 11/02/2022 - Following surgery, patients with breast cancer are faced with the question of whether additional chemotherapy is necessary and really effective. It is important that these women do not receive too much treatment –...
In honor of World Cancer Day, The Desmoid Tumor Research Foundation is celebrating the success of their virtualized tumor board program enabled through the OncoLens platform Atlanta, GA: In honor of World Cancer Day on February 4th, The...
Vabysmo (faricimab-svoa) targets and inhibits two disease pathways that drive wet age-related macular degeneration (AMD) and diabetic macular edema (DME). Vabysmo is the only injectable eye medicine approved simultaneously in the US for wet...
